“…14,15,36,37 The difficulty in achieving high enantioselectivity in these reactions have been attributed to catalyst poisoning by the nucleophilic amine and facile dissociation of the ylide intermediate from the metal center. 14,37 While significant progress was made toward overcoming these challenges, these chemocatalytic protocols require the use of precious metals (e.g., Rh, Pd), [38][39][40][41] synthetically challenging chiral ligands and/or co-catalysts, 38,[42][43][44] and/or are restricted to -aryl diazo compounds, 40,41,45 with only a few exceptions. 43,44 In this context, the development of biocatalytic alternatives would be therefore highly desirable as it will contribute to the development of sustainable and environmentally benign approaches for realizing these transformations.…”